Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix

Author： Ludwig M.   Riethmuller-Winzen H.   Felberbaum R.E.   Olivennes F.   Albano C.   Devroey P.   Diedrich K.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.75, Iss.1, 2001-01, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the ''follicle-stimulating hormone window'' combined with the gonadotropin-releasing hormone antagonist cetrorelix

By de Jong D.   Macklon N.S.   Fauser B.C.J.M.  

Fertility and Sterility, Vol. 73, Iss. 5, 2000-05 ,pp. : 1051-1054

Elsevier

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist

By Williams S.C.   Gibbons W.E.   Muasher S.J.   Oehninger S.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1068-1072

Elsevier

Access to resources Recommend Favorite

Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist

By Tavaniotou A.   Albano C.   Smitz J.   Devroey P.  

Fertility and Sterility, Vol. 77, Iss. 4, 2002-04 ,pp. : 733-737

Elsevier

Access to resources Recommend Favorite

Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

By Delvigne A.   Carlier C.   Rozenberg S.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 844-846

Elsevier

Access to resources Recommend Favorite